Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Auto Added by WPeMatico
Marvell Technology edged above expectations for its fiscal second quarter and guided higher than views for fiscal Q3. But Marvell stock fell. The post Chipmaker Marvell Edges Above Estimates But Stock Falls appeared first on Investor’s Business Daily.
CrowdStrike stock climbed amid Q2 earnings and revenue that topped estimates while the cybersecurity firm’s October quarter guidance came in above views. The post CrowdStrike Earnings Beat As AI Adoption Drives Endpoint Upgrades appeared first on Investor’s Business Daily.
Amgen and AstraZeneca’s drug, Tezspire, scored Thursday in an esophageal disease that affects an estimated 470,000 patients in the U.S. The post Amgen, AstraZeneca Score With Tezspire; Can They Take On Dupixent? appeared first on Investor’s Business Daily.
Nvidia stock jumped after the AI chipmaker delivered a beat-and-raise earnings report and gave an upbeat forecast for next year. The post Nvidia Stock Jumps On Bullish Quarterly Report, Outlook appeared first on Investor’s Business Daily.
Salesforce stock climbed amid Q2 earnings and revenue that beat Wall Street targets while guidance came in above expectations. The post Salesforce Earnings, Revenue Beat Amid Expanded Anthropic Partnership appeared first on Investor’s Business Daily.
Salesforce stock climbed amid Q2 earnings and revenue that beat Wall Street targets while guidance came in above expectations. The post Salesforce Pops As Q2 Earnings, Revenue Beat Amid Strong Guidance appeared first on Investor’s Business Daily.
Everpure stock was trading up and down after-hours despite the data storage company handily beating Q2 earnings expectations. The post Everpure Posts Earnings Beat As Revenue Growth Accelerates appeared first on Investor’s Business Daily.
CrowdStrike stock climbed amid Q2 earnings and revenue that topped estimates while the cybersecurity firm’s October quarter guidance came in above views. The post CrowdStrike Stock Climbs As Earnings, Revenue, Outlook Top Views appeared first on Investor’s Business Daily.
Okta reported Q2 earnings and revenue that topped estimates while the cybersecurity firm’s sales outlook came in above views. The post Okta Earnings Top Estimates. Cybersecurity Firm’s Sales Outlook Above Views. appeared first on Investor’s Business Daily.
Revolution Medicines won FDA approval Wednesday for the pancreatic cancer treatment that once caused its stock to skyrocket. The post FDA Approves ‘Unprecedented’ Pancreatic Cancer Drug appeared first on Investor’s Business Daily.
